De novo acquired hemophilia as an immune dysregulation phenomenon following SARS‐CoV‐2 infection
Open Access
- 24 December 2020
- journal article
- letter
- Published by Wiley in Transfusion
- Vol. 61 (3) , 989-991
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Immune Thrombocytopenia Secondary to COVID-19: a Systematic ReviewSN Comprehensive Clinical Medicine, 2020
- Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategiesAnnals of Hematology, 2020
- COVID-19 and the Coombs testBlood, 2020
- Autoimmune haemolytic anaemia associated with COVID‐19 infectionBritish Journal of Haematology, 2020
- The first case of acquired hemophilia A associated with SARS‐CoV‐2 infectionAmerican Journal of Hematology, 2020
- Lupus anticoagulant is frequent in patients with Covid‐19Journal of Thrombosis and Haemostasis, 2020
- Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)Journal of Thrombosis and Haemostasis, 2012